Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 242 clinical trials
Six Years of Follow-up After Extended Duration of Oral Anticoagulant Therapy for a First Episode of Idiopathic Pulmonary Embolism or Proximal Deep Vein Thrombosis. (Padis-Ext)

years. This risk of recurrentce is likely to continuously increase over the years as well as the risk of chronic thromboembolic pulmonary hypertension (after pulmonary embolism) or the risk of post

vitamin k
anticoagulation therapy
thrombosis
deep vein thrombosis
venous thromboembolism
  • 113 views
  • 22 Oct, 2022
  • 13 locations
VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics Management Strategies and Risk Stratification in VTE

Venous thromboembolism (VTE) with its two clinical manifestations deep vein thrombosis (DVT) and pulmonary embolism (PE) is a life-threatening disease that is associated with considerable

venous thrombosis
dvts
thrombosis
pulmonary embolism
deep vein thrombosis
  • 31 views
  • 27 Mar, 2021
  • 1 location
Ongoing Registry of Treatment of Venous Thromboembolism (RRT VTE)

Ongoing registration of patients with venous thromboembolism treated by means of antithrombotic therapy, thrombolisys, open surgery, endovenous desobstruction and stenting.

anticoagulation therapy
venous thrombosis
thrombosis
venous thromboembolism
anticoagulants
  • 0 views
  • 07 Oct, 2022
  • 1 location
Registry of Patients Prescribed Anticoagulation (STAGPOR)

lower or upper extremities, splanchnic veins, gonadal, renal, cerebral veins thrombosis and pulmonary embolism (PE). Therapy includes the whole spectrum of FDA approved anticoagulants such as "classic

  • 21 views
  • 07 Oct, 2022
  • 1 location
Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies (PULSE)

Despite advances in obstetric care, preeclampsia (PE) remains the leading cause of maternal death and disability in both developed and developing countries, contributing to over 70,000 maternal

obstetric care
eclampsia
prenatal
  • 0 views
  • 18 Jun, 2022
  • 1 location
Molecular Screening Method for Preeclampsia (PREMOM)

Preeclampsia (PE) is a major obstetric complication with short- and long-term consequences for the mother and the fetus. Early screening tools to reduce its mortality and morbidity, as well as

  • 10 views
  • 06 Nov, 2021
  • 18 locations
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications (CORONA-VTE NET)

Novel coronavirus 2019 (COVID-19) has emerged as a major international public health concern. While much of the morbidity and mortality associated with COVID-19 has been attributed to acute respiratory distress syndrome (ARDS) or end-organ failure, emerging data suggest that disorders of coagulation, in particular hypercoagulability and venous thromboembolism (VTE), may …

venous thromboembolism
d-dimer
blood clot
thromboembolism
  • 0 views
  • 20 Apr, 2022
Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation

apixaban) who visit hospital. The purpose is to analyze bleeding (major bleeding, minor bleeding), stroke, systemic embolism, death, other clinical events (acute myocardial infarction, pulmonary embolism

apixaban
transient ischemic attack
embolism
fibrillation
infarct
  • 11 views
  • 24 Feb, 2022
  • 1 location
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study

(pulmonary embolism) incidence in HM /HCT patients at the University of Toronto, and the complications associated with it (including death). In addition, the investigators want to evaluate the use, type

venous thromboembolism
cancer
hematologic malignancy
embolism
thromboembolism
  • 0 views
  • 14 Jun, 2022
  • 1 location
Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4)

Depersonalized multi-centered registry initiated to analyze dynamics of non-infectious diseases after SARS-CoV-2 infection in population of Eurasian adult patients.

covid-19
  • 0 views
  • 04 Oct, 2022
  • 1 location